Cite
Treatment of chronic hepatitis C virus infection in Rwanda with ledipasvir–sofosbuvir (SHARED): a single-arm trial
MLA
Gupta, Neil, et al. “Treatment of Chronic Hepatitis C Virus Infection in Rwanda with Ledipasvir–sofosbuvir (SHARED): A Single-Arm Trial.” The Lancet Gastroenterology & Hepatology, vol. 4, no. 2, Feb. 2019, pp. 119–26. EBSCOhost, https://doi.org/10.1016/S2468-1253(18)30382-0.
APA
Gupta, N., Mbituyumuremyi, A., Kabahizi, J., Ntaganda, F., Muvunyi, C. M., Shumbusho, F., Musabeyezu, E., Mukabatsinda, C., Ntirenganya, C., Van Nuil, J. I., Kateera, F., Camus, G., Damascene, M. J., Nsanzimana, S., Mukherjee, J., & Grant, P. M. (2019). Treatment of chronic hepatitis C virus infection in Rwanda with ledipasvir–sofosbuvir (SHARED): a single-arm trial. The Lancet Gastroenterology & Hepatology, 4(2), 119–126. https://doi.org/10.1016/S2468-1253(18)30382-0
Chicago
Gupta, Neil, Aimable Mbituyumuremyi, Jules Kabahizi, Fabien Ntaganda, Claude Mambo Muvunyi, Fabienne Shumbusho, Emmanuel Musabeyezu, et al. 2019. “Treatment of Chronic Hepatitis C Virus Infection in Rwanda with Ledipasvir–sofosbuvir (SHARED): A Single-Arm Trial.” The Lancet Gastroenterology & Hepatology 4 (2): 119–26. doi:10.1016/S2468-1253(18)30382-0.